BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ehrmann S, Schmid O, Darquenne C, Rothen-Rutishauser B, Sznitman J, Yang L, Barosova H, Vecellio L, Mitchell J, Heuze-Vourc'h N. Innovative preclinical models for pulmonary drug delivery research. Expert Opin Drug Deliv 2020;17:463-78. [PMID: 32057260 DOI: 10.1080/17425247.2020.1730807] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Movia D, Prina-Mello A. Preclinical Development of Orally Inhaled Drugs (OIDs)-Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models? Animals (Basel) 2020;10:E1259. [PMID: 32722259 DOI: 10.3390/ani10081259] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Doryab A, Taskin MB, Stahlhut P, Schröppel A, Orak S, Voss C, Ahluwalia A, Rehberg M, Hilgendorff A, Stöger T, Groll J, Schmid O. A Bioinspired in vitro Lung Model to Study Particokinetics of Nano-/Microparticles Under Cyclic Stretch and Air-Liquid Interface Conditions. Front Bioeng Biotechnol 2021;9:616830. [PMID: 33634087 DOI: 10.3389/fbioe.2021.616830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Roh EH, Fromen CA, Sullivan MO. Inhalable mRNA vaccines for respiratory diseases: a roadmap. Curr Opin Biotechnol 2021;74:104-9. [PMID: 34894574 DOI: 10.1016/j.copbio.2021.10.017] [Reference Citation Analysis]
4 Cei D, Doryab A, Lenz AG, Schröppel A, Mayer P, Burgstaller G, Nossa R, Ahluwalia A, Schmid O. Development of a dynamic in vitro stretch model of the alveolar interface with aerosol delivery. Biotechnol Bioeng 2021;118:690-702. [PMID: 33058147 DOI: 10.1002/bit.27600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yang S, Liu P, Jiang Y, Wang Z, Dai H, Wang C. Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis. Front Cell Dev Biol 2021;9:639657. [PMID: 33768094 DOI: 10.3389/fcell.2021.639657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Moreira A, Müller M, Costa PF, Kohl Y. Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem Cells. Adv Biol (Weinh) 2021;:e2101139. [PMID: 34962104 DOI: 10.1002/adbi.202101139] [Reference Citation Analysis]
7 Wu L, Rodríguez-Rodríguez C, Cun D, Yang M, Saatchi K, Häfeli UO. Quantitative comparison of three widely-used pulmonary administration methods in vivo with radiolabeled inhalable nanoparticles. Eur J Pharm Biopharm 2020;152:108-15. [PMID: 32437751 DOI: 10.1016/j.ejpb.2020.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Jakaria MG, Sorkhdini P, Yang D, Zhou Y, Meenach SA. Lung cell membrane-coated nanoparticles capable of enhanced internalization and translocation in pulmonary epithelial cells. Int J Pharm 2021;613:121418. [PMID: 34954003 DOI: 10.1016/j.ijpharm.2021.121418] [Reference Citation Analysis]
9 Doryab A, Taskin MB, Stahlhut P, Schröppel A, Wagner DE, Groll J, Schmid O. A Biomimetic, Copolymeric Membrane for Cell‐Stretch Experiments with Pulmonary Epithelial Cells at the Air‐Liquid Interface. Adv Funct Mater 2021;31:2004707. [DOI: 10.1002/adfm.202004707] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Kohl Y, Biehl M, Spring S, Hesler M, Ogourtsov V, Todorovic M, Owen J, Elje E, Kopecka K, Moriones OH, Bastús NG, Simon P, Dubaj T, Rundén-Pran E, Puntes V, William N, von Briesen H, Wagner S, Kapur N, Mariussen E, Nelson A, Gabelova A, Dusinska M, Velten T, Knoll T. Microfluidic In Vitro Platform for (Nano)Safety and (Nano)Drug Efficiency Screening. Small 2021;17:e2006012. [PMID: 33458959 DOI: 10.1002/smll.202006012] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Horstmann JC, Thorn CR, Carius P, Graef F, Murgia X, de Souza Carvalho-Wodarz C, Lehr CM. A Custom-Made Device for Reproducibly Depositing Pre-metered Doses of Nebulized Drugs on Pulmonary Cells in vitro. Front Bioeng Biotechnol 2021;9:643491. [PMID: 33968912 DOI: 10.3389/fbioe.2021.643491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Enlo-scott Z, Bäckström E, Mudway I, Forbes B. Drug metabolism in the lungs: opportunities for optimising inhaled medicines. Expert Opinion on Drug Metabolism & Toxicology 2021;17:611-25. [DOI: 10.1080/17425255.2021.1908262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Carius P, Dubois A, Ajdarirad M, Artzy-Schnirman A, Sznitman J, Schneider-Daum N, Lehr CM. PerfuPul-A Versatile Perfusable Platform to Assess Permeability and Barrier Function of Air Exposed Pulmonary Epithelia. Front Bioeng Biotechnol 2021;9:743236. [PMID: 34692661 DOI: 10.3389/fbioe.2021.743236] [Reference Citation Analysis]
14 Bomberna T, Koudehi GA, Claerebout C, Verslype C, Maleux G, Debbaut C. Transarterial drug delivery for liver cancer: numerical simulations and experimental validation of particle distribution in patient-specific livers. Expert Opin Drug Deliv 2021;18:409-22. [PMID: 33210955 DOI: 10.1080/17425247.2021.1853702] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Guillon A, Pardessus J, L'Hostis G, Fevre C, Barc C, Dalloneau E, Jouan Y, Bodier-Montagutelli E, Perez Y, Thorey C, Mereghetti L, Cabrera M, Riou M, Vecellio L, Le Guellec S, Heuzé-Vourc'h N. Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation. Br J Pharmacol 2021;178:3829-42. [PMID: 33974271 DOI: 10.1111/bph.15526] [Reference Citation Analysis]
16 Enlo-scott Z, Swedrowska M, Forbes B. Epithelial permeability and drug absorption in the lungs. Inhaled Medicines. Elsevier; 2021. pp. 267-99. [DOI: 10.1016/b978-0-12-814974-4.00004-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cidem A, Bradbury P, Traini D, Ong HX. Modifying and Integrating in vitro and ex vivo Respiratory Models for Inhalation Drug Screening. Front Bioeng Biotechnol 2020;8:581995. [PMID: 33195144 DOI: 10.3389/fbioe.2020.581995] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Barron SL, Saez J, Owens RM. In Vitro Models for Studying Respiratory Host-Pathogen Interactions. Adv Biol (Weinh) 2021;5:e2000624. [PMID: 33943040 DOI: 10.1002/adbi.202000624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Matera MG, Calzetta L, Ora J, Rogliani P, Cazzola M. Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs. Expert Opin Drug Deliv 2021;18:891-906. [PMID: 33412922 DOI: 10.1080/17425247.2021.1873271] [Reference Citation Analysis]